Pdt Partners, LLC Heron Therapeutics, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $307,597 - $638,435	-136,710 Reduced 44.9%	167,749 $419,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $174,163 - $351,600	-65,475 Reduced 17.7%	304,459 $1.29 Million
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $298,763 - $817,052	-129,897 Reduced 25.99%	369,934 $1.03 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $2.02 Million - $4.34 Million	436,461 Added 688.75%	499,831 $2.86 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $529,139 - $798,462	63,370 New	63,370 $579,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $478,091 - $665,797	-36,028 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $522,045 - $746,500	36,028 New	36,028 $584,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.